General MedicationsINTRAVENOUSStandard
PEMETREXED
PEMETREXED DISODIUM
Standard Dose
EQ 100MG/10ML BASE (10MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview PEMETREXED is listed in Drugs@FDA under application 215179 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient PEMETREXED DISODIUM Form and strength SOLUTION;INTRAVENOUS - EQ 100MG/10ML BASE (10MG/ML) Sponsor SHILPA Submission history Latest submission status date: 2024-11-15 00:00:00.
Structured Monograph
Clinical summary
Approval overview PEMETREXED is listed in Drugs@FDA under application 215179 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient PEMETREXED DISODIUM Form and strength SOLUTION;INTRAVENOUS - EQ 100MG/10ML BASE (10MG/ML) Sponsor SHILPA Submission history Latest submission status date: 2024-11-15 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.